🔍 Observations
Topline
- Consolidated revenue from operations surged 18.2% YoY (₹1,48,478 Cr → ₹1,75,431 Cr), led by Building Materials (+24.3%) and Financial Services (+11.8%) — both structurally large segments with compounding scale.
- Q4FY26 revenue hit ₹51,101 Cr, up 15.4% YoY and 15.3% QoQ, suggesting Q4 seasonality tailwinds and demand acceleration in cement/paints.
- Building Materials contributed ₹1,01,202 Cr (57.7% of segment revenue) — crossed the ₹1 lakh Cr milestone for the first time, reflecting UltraTech + Birla Opus scale-up.
Bottomline
- Net profit jumped 32.8% YoY (₹7,756 Cr → ₹10,300 Cr); Q4FY26 alone delivered ₹3,802 Cr, up 27.9% YoY — strongest quarterly print.
- EPS expanded from ₹55.57 to ₹73.21 (basic), a 31.7% YoY jump on a stable share count — purely earnings-driven, not dilution.
- Total tax expense rose 35.9% YoY, absorbing some profit upside; effective tax rate held near 28.8% — slightly elevated but not alarming.
Margins
- Consolidated EBIT margin (segment EBIT / segment revenue): ₹25,693 Cr on ₹1,77,217 Cr = 14.5% vs 13.2% in FY25 — 130 bps expansion YoY.
- Building Materials EBIT grew 36.2% (₹12,012 Cr → ₹16,364 Cr) on 24.3% revenue growth — operating leverage clearly visible; this segment is the primary margin engine.
- Net profit margin (PAT / Revenue from Ops): 10,300 / 1,75,431 = 5.87% vs 5.22% in FY25 — 65 bps improvement, meaningful for a conglomerate of this size.
Growth Trajectory
- Cellulosic Fibres EBIT: +14.9% YoY (₹1,524 Cr → ₹1,751 Cr) on 7.6% revenue growth — margin improvement driving profitability, not just volume.
- Financial Services EBIT: +13.8% YoY (₹4,650 Cr → ₹5,293 Cr) — NBFC/HFC loan book growing, finance costs rising in tandem but EBIT spread holding.
- Chemicals EBIT: +16.4% YoY (₹1,208 Cr → ₹1,406 Cr) — steady contributor, not high-growth but consistent.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Building Materials crossed ₹1 lakh Cr revenue — UltraTech + Birla Opus hitting scale together; cement consolidation benefits are compounding.
- EBIT margin expanded 130 bps YoY — broad-based across segments, signaling operating leverage, not just topline flattery.
- PAT growth (32.8%) outpaced revenue growth (18.2%) — earnings quality improving, not just size.
- EPS at ₹73.21, up 31.7% YoY — entirely organic; share count unchanged at ~136 Cr shares.
- Cellulosic Fibres EBIT margin improving despite a commodity segment — disciplined cost control or favourable input costs giving a structural lift.
- Financial Services EBIT steady at ₹5,293 Cr — NBFC/HFC book expansion generating incremental spread despite rising cost of funds.
- Q4FY26 PBT of ₹5,078 Cr — strongest quarterly PBT in the dataset; FY26 exiting at momentum.
🔴 Red Flags
- Operating cash flow deeply negative: -₹17,810 Cr (FY26) vs -₹17,170 Cr (FY25) — the NBFC/HFC loan book disbursement (-₹43,435 Cr) structurally drains operating CFO; not a transient issue.
- Gross debt expansion: Non-current borrowings grew ₹1,23,927 Cr → ₹1,56,829 Cr (+26.5%) — ₹32,900 Cr incremental non-current debt in one year is significant; leverage trajectory warrants monitoring.
- Current borrowings also up: ₹59,722 Cr → ₹68,119 Cr — total borrowings (NC + current) rose from ₹1,83,649 Cr to ₹2,24,948 Cr, a ₹41,299 Cr increase YoY.
- Entire capex funded by financing: Net investing outflow -₹17,803 Cr + operating outflow -₹17,810 Cr = covered by financing inflows of +₹33,523 Cr — the business is borrowing to fund both growth capex and working capital.
- Cash and equivalents fell: ₹4,883 Cr → ₹2,798 Cr — tightening liquidity buffer despite large financing inflows.
- Exceptional items recurring: -₹322.92 Cr in FY26 vs -₹238.85 Cr in FY25 — not truly exceptional if they appear every year.
- Trade payables to MSME up sharply: ₹520 Cr → ₹926 Cr (+78%) — potential compliance/regulatory risk under MSME payment norms.
📊 Balance Sheet Analysis
- Total equity grew to ₹1,69,865 Cr (vs ₹1,57,813 Cr) — solid net worth base, but total assets ballooned to ₹5,69,555 Cr; asset-to-equity ratio at ~3.4x reflects a heavily leveraged consolidated structure.
- NBFC/HFC loan book (NC Loans ₹1,50,501 Cr + Current Loans ₹43,943 Cr = ₹1,94,444 Cr) now represents ~34% of total assets — asset quality of this book is the single largest balance sheet risk, not visible in P&L yet.
- Goodwill at ₹21,596 Cr + Other Intangibles ₹12,313 Cr = ₹33,909 Cr — acquisition-heavy history; any impairment would directly hit net worth.
- Insurance liabilities (NC + Current): ₹1,07,377 Cr offset by insurance investments of ~₹1,10,508 Cr — broadly matched, but actuarial and market risk embedded.
💰 Cash Flow Analysis
- Operating CFO structurally negative due to NBFC/HFC disbursements (-₹43,435 Cr); stripping this out, core industrial operating cash generation is positive — but the consolidated entity cannot be assessed on industrial FCF metrics alone.
- Capex of ₹15,626 Cr (vs ₹17,181 Cr in FY25) — moderation in absolute capex despite revenue scale-up is a mild positive; Building Materials expansion may be maturing.
- Financing activities generated ₹33,523 Cr — net new borrowings of ~₹38,852 Cr (proceeds minus repayments) funded the entire cash shortfall; the balance sheet is a funding machine for the NBFC and insurance arms.
- Free cash flow (CFO + Capex): -₹17,810 Cr – ₹15,626 Cr = -₹33,436 Cr — deeply negative; not a concern for NBFC/Insurance segments structurally, but highlights that industrial segments are not yet self-funding the group’s ambitions.
💡 Investment Outlook
Grasim’s FY26 is a strong earnings story — 32.8% PAT growth, 130 bps EBIT margin expansion, and a Building Materials segment that crossed a landmark scale threshold — but the investment thesis is complicated by the conglomerate’s structural cash consumption.
The NBFC/HFC book growing at pace is both a growth driver and a hidden credit risk that consolidated financials obscure.
Margin inflection in Building Materials (including Birla Opus maturing) remains the key re-rating catalyst, while debt trajectory and NBFC asset quality are the variables that could either validate or derail the bull case.
Investors need to track segment-level EBIT margins and loan book NPA disclosures alongside consolidated PAT to form a complete view.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.